Shares of Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) were down 6.8% during trading on Wednesday . The company traded as low as $7.82 and last traded at $7.85. Approximately 6,561,256 shares traded hands during trading, an increase of 11% from the average daily volume of 5,911,325 shares. The stock had previously closed at $8.42.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on the company. Zacks Research cut Tilray Brands from a "hold" rating to a "strong sell" rating in a research report on Tuesday, January 13th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Tilray Brands in a research note on Wednesday, January 21st. Canaccord Genuity Group initiated coverage on shares of Tilray Brands in a research note on Tuesday. They set a "hold" rating for the company. Wall Street Zen raised Tilray Brands from a "strong sell" rating to a "hold" rating in a research note on Saturday, October 11th. Finally, Roth Mkm reduced their price objective on Tilray Brands from $20.00 to $10.00 and set a "neutral" rating on the stock in a research note on Tuesday, January 20th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Reduce" and a consensus target price of $13.33.
Read Our Latest Report on TLRY
Tilray Brands Stock Down 6.8%
The stock's fifty day simple moving average is $9.43 and its two-hundred day simple moving average is $10.97. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.81 and a quick ratio of 1.72. The company has a market capitalization of $914.60 million, a price-to-earnings ratio of -0.36 and a beta of 1.77.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Thursday, January 8th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.27). Tilray Brands had a negative net margin of 251.69% and a negative return on equity of 6.35%. The company had revenue of $217.51 million for the quarter, compared to analyst estimates of $211.15 million. During the same quarter in the prior year, the firm earned ($0.03) EPS. On average, sell-side analysts predict that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Tilray Brands
A number of hedge funds have recently modified their holdings of TLRY. Tidal Investments LLC raised its position in shares of Tilray Brands by 15.0% in the second quarter. Tidal Investments LLC now owns 28,971,835 shares of the company's stock valued at $12,006,000 after purchasing an additional 3,776,410 shares during the period. Millennium Management LLC boosted its stake in Tilray Brands by 281.0% during the 3rd quarter. Millennium Management LLC now owns 4,942,319 shares of the company's stock valued at $8,550,000 after purchasing an additional 3,645,060 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Tilray Brands in the 3rd quarter worth approximately $5,813,000. Ausdal Financial Partners Inc. acquired a new position in shares of Tilray Brands during the second quarter worth approximately $939,000. Finally, Scientech Research LLC bought a new stake in shares of Tilray Brands in the third quarter valued at approximately $1,748,000. 9.35% of the stock is owned by institutional investors and hedge funds.
About Tilray Brands
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.